A recent report published by Infinium Global Research on competent cells market provides in-depth analysis of segments and sub-segments in the global as well as regional competent cells market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional competent cells market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global competent cells market. According to the report, the global competent cells market is projected to grow at a CAGR of 10.4% over the forecast period of 2019-2025.

Market Insight

Competent cells have a property to incorporate foreign DNA into it. These are bacterial cells that accept the extrachromosomal DNA and plasmid. The ability to take up external DNA is called natural competence. All bacterias don’t have such natural competence and thus minimizes the chance of recombinational development. The walls of competent cells are made permeable with the use of heat shock and calcium chloride. Competent cells are routinely used in molecular cloning that propagates and maintains cloned DNA in plasmids.

The rising commercial demand for molecular cloned products and recombinant proteins drives the growth of competent cells market. The rising molecular cloning research and the emergence of new technologies will augment the expansion of competent cells market. Further, support from the government for the advancement of DNA technologies and increasing demand for cloning products are the major factors contributing to the development of competent cells market. All bacterias are not naturally competent thus researchers developed artificial competence. The cells are made competent by using induced methods such as chemicals mediated methods. The adoption of artificial intelligence for developing new products led to market growth. Additionally, rising research and development on DNA technologies in various research institutes contribute to the development of competent cells market. The growing need for advanced products to treat diseases bolsters the growth of the market. In addition, the development of molecular engineering and favorable regulatory policies stimulate market growth. On the flip side, the high cost of competent cell kits hinders the growth of competent cells market. Moreover, the emergence of several applications of competent cells creates numerous opportunities for the growth of competent cells market.

Geographically, the global competent cells market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is expected to have a dominant share in the global competent cells market. The growth of the market in North America is attributed to growing research activities related to recombinant therapy in the region. The growing biotechnology and pharmaceutical industries and the presence of leading key players in North America stimulate the growth of the market in the region. Europe has a significant growth rate in the global competent cells market owing to a surge in the need for recombinant products. Asia-Pacific is anticipated to have a healthy CAGR in the global competent cells market over the forecast period. The rising investments in research and development in developing countries such as India, China stimulates the growth of competent cells market in Asia-Pacific.

Segment Covered

The report on global competent cells market covers segments such as product type, application, and end-user. On the basis of product type, the sub-markets include chemically competent cells, and electrocompetent cells. On the basis of application, the sub-markets include protein expression, cloning, and other applications. On the basis of end-user, the sub-markets include contract manufacturing organizations, research organizations, academic research institutes, and pharmaceutical and biotechnology companies.

Companies Profiled:

The report provides profiles of the companies in the market such as Merck KGaA, Takara Bio, Inc., Illumina, Inc., Qiagen N.V., OriGene Technologies, Inc., Zymo Research, Thermo Fisher Scientific, Inc., Promega Corporation, TransGen Biotech Co., Ltd., Bio-Rad Laboratories, Inc., and Other companies.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of competent cells market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.